BellSoft, the creator of Liberica JDK, a progressive Java runtime for the most complete Java experience and a leading OpenJDK contributor, today announced a major upgrade to Liberica JDK Performance ...

Results from a retrospective study found that Amtagvi (lifileucel) achieved a 48.8% objective response rate in patients with ...